Europe Clinical Nutrition Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

Europe Clinical Nutrition Market Analysis

The Europe Clinical Nutrition Market is expected to register a CAGR of 6.2% during the forecast period (2022-2027).

COVID-19 infection has become a major public health concern, and clinical nutrition plays a crucial role in preventing infection and treating infection-associated malnutrition. For instance, the in July 2020 European Society for Clinical Nutrition and Metabolism issued guidelines related to nutritional management in ICU patients infected with COVID-19. Thus, a positive impact can be expected on the market studied due to COVID-19.

The major factors attributing to the growth of the market are increasing the prevalence of metabolic disorders, and high spending on healthcare. For instance, according to the 2022 statistics published by the International Diabetes Federation (IDF) Diabetes Atlas, an estimated 61 million adults (20-79 years old) in the International Diabetes Federation Europe region had diabetes in 2021. In addition, as per the same source, 295,000 children and adolescents (0-19 years) in the region have type 1 diabetes. Thus, the increasing burden of diabetes in the region is expected to increase the demand for dietary therapy, thereby boosting the market growth.

In addition, according to the Europe 2021 Aging Report, 21% of the Europe population was aged 65 years or above and this number is projected to increase by 14% by 2100. Thus, the increasing number of the geriatric population who are more prone to develop metabolic disorders is likely to increase the demand for nutrition therapy to prevent acute complications, such as metabolic decompensation, and/or to prevent long-term complications of the given disorder, which is expected to augment the market growth over the forecast period.

Furthermore, the increasing government initiatives in launching guidelines and aware people regarding clinical nutrition are also contributing to the growth of the market. For instance, in June 2020, the European Society for Clinical Nutrition and Management launched its guideline on clinical nutrition in inflammatory bowel disease (IBD) as an app version for smartphones and tablets for professionals (physicians, nurses, dieticians, nutritionists, etc).

However, the unwillingness of hospitals and in-house pharmacies/ dispensaries to maintain the required stock of clinical nutrition products and imprecise perception about clinical nutrition are likely to restrain the market growth over the forecast period.

Europe Clinical Nutrition Market Trends

This section covers the major market trends shaping the Europe Clinical Nutrition Market according to our research experts:

Nutritional Support for Metabolic Disorders Segment Expects to Register a High CAGR in the Forecast Period

Europe Clinical Nutrition Industry Segmentation

As per the scope of the report, clinical malnutrition refers to a condition that can be treated with clinical intervention by using specialized nutrients that are considered proper medications rather than supplements. Clinical nutrition is largely concerned with the prevention, diagnosis, and management of nutritional alterations in individuals who have chronic illnesses and disorders. Clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. The Europe Clinical Nutrition Market is segmented By Route of Administration (Oral and Enteral, Parenteral), By Application (Nutritional Support for Malnutrition, Nutritional Support for Metabolic Disorders, Nutritional Support for Gastrointestinal Diseases, Nutritional Support for Cancer, Nutritional Support in Neurological Diseases and Nutritional Support in Other Diseases, By End User (Pediatric and Adult) and Country. The report offers the value (in USD million) for the above segments.